The Federal Trade Commission (FTC) is facing a pivotal moment as it prepares to engage in its first major antitrust case against Meta Platforms, Inc. This case is seen as a critical test for the FTC under the leadership of President Donald Trump, who recently solidified control by firing two Democratic commissioners. The FTC's chair, Andrew Ferguson, has decided to involve himself in ongoing litigation concerning pharmacy benefit managers (PBMs) and insulin pricing, which had been stalled due to the lack of commissioners. Meanwhile, two staffers from the Department of Government Efficiency (DOGE) have recently joined the FTC, marking a significant shift in the agency's approach to regulation. Their arrival comes just days before the high-stakes trial against Meta, emphasizing the agency's new direction under Trump's administration.